Lowenstein E. , Hallowell P., Levine FH, et al: Cardiovascular response to large doses of intravenous morphine in man. N Engl J Med281:1389-1393, 1969
2.
Stanley TH, Gray NG, Stanford W., et al: The effects of high-dose morphine on fluid and blood requirements in open-heart operations. Anesthesiology38:536-541. 1973
3.
Stanley TH, Webster LR: Anesthetic requirements and cardiovascular effects of fentanyl-oxygen and fentanyl-diazepam-oxygen anesthesia in man. Anesth Analg57:411-416,1978
4.
Scott JC, Stanski DR: Decreased fentanyl and alfentanil dose requirements with age: A simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharm Exp Ther240:159-166, 1987
5.
Minto CF, Schnider TW, Egan TD, et al: Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. Anesthesiology86, 1997.
6.
Schwilden H. : A general method for calculating the dosage scheme in linear pharmacokinetics. Eur J Clin Pharmacol20:379-386, 1981
7.
Hughes MA, Glass Psa, Jacobs JR: Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology76:334-341, 1992
8.
Shafer A., Doze VA, Shafer SL, et al: Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia. Anesthesiology69:348-356, 1988
9.
Glass Psa, Jacobs JR, Smith RL, et al: Pharmacokinetic model-driven infusion of fentanyl: Assessment of accuracy. Anesthesiology73:1082-1090, 1990
10.
Ausems ME, Hug CC Jr, Stanski DR, et al: Plasma concentrations of alfentanil required to supplement nitrous oxide anesthesia for general surgery. Anesthesiology65:362-373, 1986
Sheiner LB, Stanski DR, Vozeh S., et al: Simultaneous modelling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine. Clin Pharm Ther25:358-371, 1979
13.
Scott JC, Ponganis KV, Stanski DR: EEG quantitation of nacrotic effect: The comparative pharmacodynamics of fentanyl and alfentanil. Anesthesiology62:234-241. 1985
14.
Glass Psa, Hardman D., Kamiyama Y., et al: Preliminary pharmacokinetics and pharmacodynamics of an ultrashortacting opioid: Remifentanil (GI87084B). Anesth Analg77:1031-1040,1993
15.
Shafer SL, Siegel LC, Cooke JE, et al: Testing computer-controlled infusion pumps by simulation. Anesthesiology68:261-266, 1988
16.
Short TG, Galletly DC, Plummer JL: Hypnotic and anaesthetic action of thiopentone and midazolam alone and in combination. Br J Anaesth66:13-19, 1991
17.
Short TG, Chui PT: Propofol and midazolam act synergistically in combination. Br J Anaesth67:539-545, 1991
18.
Short TG, Plummer JL, Chui PT: Hypnotic and anaesthetic interactions between midazolam, propofol and alfentanil . Br J Anaesth69:162-167, 1992
19.
Reves JG, Kissin I., Fournier SE, et al: Additive negative inotropic effect of a combination of diazepam and fentanyl. Anesth Analg63:93-100, 1984
20.
Kissin I., Mason JO, Bradley EL: Morphine and fentanyl hypnotic interactions with thiopental. Anesthesiology67:331-335,1987
21.
Sebel PS, Glass Psa, Fletcher JE, et al: Reduction of the MAC of desflurane with fentanyl. Anesthesiology76:52-59, 1992
22.
McEwan AI, Smith C., Dyar O., et al: Isoflurane MAC reduction by fentanyl. Anesthesiology78:864-869, 1993
23.
Brunner MD, Braithwaite P., Jhaveri R., et al: The MAC reduction of isoflurane by sufentanil. Br J Anaesth72:42-46, 1994
24.
Westmoreland C., Sebel PS, Groper A., et al: Reduction of isoflurane MAC by fentanyl or alfentanil. Anesthesiology77:A394, 1992
25.
Lang E., Kapila A., Shlugman D., et al: The reduction of isoflurane minimal alveolar concentration by remifentanil. Anesthesiology85:721-827, 1996
26.
Smith C., McEwan AI, Jhaveri R., et al:The interaction of fentanyl on the Cp50 of propofol for loss of consciousness and skin incision. Anesthesiology81:820-828, 1994
27.
Vuyk J., Engbers Fhm, Lemmens Hjm, et al: Pharmacodynamics of propofol in female patients. Anesthesiology77:3-9,1992
Schwilden H. , Schüttler J., Stoekel H.: Pharmacokinetics as applied to total intravenous anaesthesia: Theoretical considerations. Anaesthesia38:51-52, 1983
30.
Schüttler J. , Schwilden H., Stoekel H.: Pharmacokinetics as applied to total intravenous anaesthesia: Practical implications. Anaesthesia38:53-56, 1983
31.
Glass Psa, Shafer SL, Jacobs JR, et al: Intravenous drug delivery systems, in Miller RD (ed): Anesthesia. New York, NY, Churchill Livingstone, 1994, pp 389-416
32.
Bailey JM, Mora CT, Shafer SL, et al: Pharmacokinetics of propofol in adult patients undergoing coronary revascularization. Anesthesiology81:1288-1297, 1996
33.
Fiset P., Mathers L., Engstrom R., et al: Pharmacokinetics of computer-controlled alfentanil administration in children undergoing cardiac surgery. Anesthesiology83:944-955,1995
34.
Bailey PL, Stanley TH: Intravenous opioid anesthetics, in Miller RD (ed): Anesthesia. New York, NY, Churchill Livingstone, 1994, pp 291-387
35.
Glass Psa: Remifentanil: A new opioid. J Clin Anesth7:558-563, 1995